Four drug companies have canceled or reduced price increases after a drug pricing law in California took effect, according to Bloomberg. More: Pharmas call off price hikes after California law forces new warnings: report Source: fierce
read morePfizer’s shaking itself up again with some moves that put its branded drug business in charge of two big challenges: biosimilars, which need brand-level attention, and injectable hospital drugs, now beset by manufacturing woes. And with consumer health going solo,
read moreJohnson & Johnson immunology newcomer Tremfya is looking to follow in the footsteps of its big brother Stelara. The company launched a phase 2/3 clinical trial program to test the therapy in Crohn’s disease, a new indication that would broaden
read moreTally another win for Bristol-Myers Squibb’s immunotherapy combination. Its Opdivo-Yervoy pairing grabbed an FDA approval in rare types of colon cancer for patients whose disease advanced on other treatments. More: Bristol-Myers Squibb's Opdivo-Yervoy combo wins right to challenge Merck's Keytruda
read moreNICE has published new guidelines recommending use of a chemical dye to assist neurosurgeons in removing brain tumours. More: NICE backs use of dye for brain tumour removal Source: News
read moreNHS England has appointed a specialist GP to encourage the spread of innovations that integrate health and social care throughout England. More: NHS England appoints national clinical advisor for primary care Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals